In China, a CD4 cell count ≤ 350 cells/μL is recommended as a criterion (regardless of WHO clinical stage of HIV/AIDS) for medical eligibility for the initiation of antiretroviral therapy among PLWHA. The gene discussed is CD4; the disease is AIDS.